Goldman Sachs’s Vor Biopharma VOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $293K | Buy |
180,788
+95,843
| +113% | +$155K | ﹤0.01% | 4535 |
|
|
2025
Q1 | $60.9K | Buy |
84,945
+58,247
| +218% | +$41.8K | ﹤0.01% | 4897 |
|
|
2024
Q4 | $29.6K | Sell |
26,698
-1,529
| -5% | -$1.7K | ﹤0.01% | 4883 |
|
|
2024
Q3 | $19.8K | Sell |
28,227
-347,115
| -92% | -$243K | ﹤0.01% | 4705 |
|
|
2024
Q2 | $375K | Buy |
375,342
+282,171
| +303% | +$282K | ﹤0.01% | 4098 |
|
|
2024
Q1 | $221K | Buy |
93,171
+54,835
| +143% | +$130K | ﹤0.01% | 4302 |
|
|
2023
Q4 | $86.3K | Buy |
38,336
+12,774
| +50% | +$28.7K | ﹤0.01% | 4485 |
|
|
2023
Q3 | $54.2K | Sell |
25,562
-16,217
| -39% | -$34.4K | ﹤0.01% | 4476 |
|
|
2023
Q2 | $129K | Sell |
41,779
-51,500
| -55% | -$159K | ﹤0.01% | 4520 |
|
|
2023
Q1 | $502K | Buy |
+93,279
| New | +$502K | ﹤0.01% | 4072 |
|
|
2022
Q4 | – | Sell |
-19,062
| Closed | -$76K | – | 5366 |
|
|
2022
Q3 | $76K | Sell |
19,062
-8,470
| -31% | -$33.8K | ﹤0.01% | 4975 |
|
|
2022
Q2 | $137K | Buy |
27,532
+1,925
| +8% | +$9.58K | ﹤0.01% | 5018 |
|
|
2022
Q1 | $155K | Buy |
25,607
+8,370
| +49% | +$50.7K | ﹤0.01% | 5176 |
|
|
2021
Q4 | $200K | Buy |
+17,237
| New | +$200K | ﹤0.01% | 4998 |
|